Pay in 4 interest-free payments of $25.50 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC)
SR9011 was used at 5-10 µM concentration in vitro and in cellular assays
is a secreted phospholipase A2 (sPLA2) inhibitor (IC50 = 50 - 750 nM for a range of sPLA2 isoforms)
Chemical Name: (10S
[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])N(CCC1=CC=CS1)[C@@H]1CC2=CC=CC(O)=C2CC1
Trimebutine maleate Catalog No.:M8070-10 Temsirolimus (CCI-779) is an intravenousTrimebutine Maleate is a drug with antimuscarinic and weak mu opioid agonist effects. Trimebutine Maleate modulates the calcium and potassium channels, relieves abdominal pain in patients with irritable bowel syndrome. Trimebutine Maleate is used for treatment of irritable bowel syndrome and other gastrointestinal disorders. Product information CAS Number: 34140 59 5 Molecular Weight: 503. 54 Formula: C26H33NO9 Synonym: Triton maleate Cerekinon
US$ 39.99
US$ 49.99
US$ 38.00
US$ 38.00
US$ 38.00
US$ 38.00
US$ 180.00
US$ 44.00
US$ 38.00
US$ 44.00
US$ 38.00
US$ 45.00
US$ 40.00
US$ 38.00
US$ 25.00
US$ 38.00
US$ 79.00